Clinical Trials in Shanghai Shi, China
Locations / Shanghai Shi, China
Delta Trials hosts 13 clinical trials conducted in Shanghai Shi, China, making it a notable site of clinical research activity. These trials covering 19 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Shanghai Shi.
13
Total Trials
19
Conditions
1
Terminated since 2020
Browse by condition (19 total)
- Non-small cell lung cancer (nsclc) 2 trialsAll Non-small cell lung cancer (nsclc) trials
- All Metastatic castration-resistant prostate cancer trials
- End stage kidney disease 1 trialAll End stage kidney disease trials
- Metastatic colorectal cancer 1 trialAll Metastatic colorectal cancer trials
- Pancreatic ductal adenocarcinoma 1 trialAll Pancreatic ductal adenocarcinoma trials
- Sjogren's syndrome 1 trialAll Sjogren's syndrome trials
- Carcinoma, non-small-cell lung 1 trialAll Carcinoma, non-small-cell lung trials
- Age-related macular degeneration 1 trialAll Age-related macular degeneration trials
- All Polypoidal choroidal vasculopathy trials
- Pathological myopia 1 trialAll Pathological myopia trials
- All Metastatic non small cell lung cancer trials
- Ovarian cancer 1 trialAll Ovarian cancer trials
- All Atherosclerotic cardiovascular disease trials
- Progressive pulmonary fibrosis 1 trialAll Progressive pulmonary fibrosis trials
- All Atherosclerotic cardiovascular disease in patients with eskd trials
- Advanced colorectal cancer 1 trialAll Advanced colorectal cancer trials
- Conbercept 1 trialAll Conbercept trials
- Pharmacogenomic 1 trialAll Pharmacogenomic trials
- Obsessive-compulsive disorder 1 trialAll Obsessive-compulsive disorder trials